These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6405075)

  • 1. In vivo platelet activation with in vitro hyperaggregability to arachidonic acid in renal allograft recipients.
    Frampton G; Parbtani A; Marchesi D; Duffus P; Livio M; Remuzzi G; Cameron JS
    Kidney Int; 1983 Mar; 23(3):506-13. PubMed ID: 6405075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro thromboxane synthesis of depleted blood platelets following renal transplantation.
    Scharf RE
    Thromb Haemost; 1990 Aug; 64(1):161-4. PubMed ID: 2148845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for chronic platelet hyperaggregability and in vivo activation in cyclosporin-treated renal allograft recipients.
    Cohen H; Neild GH; Patel R; Mackie IJ; Machin SJ
    Thromb Res; 1988 Jan; 49(1):91-101. PubMed ID: 2450411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquisition and aggregation of canine blood platelets: basic mechanisms of function and differences because of breed origin.
    Clemmons RM; Meyers KM
    Am J Vet Res; 1984 Jan; 45(1):137-44. PubMed ID: 6422804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis.
    Di Minno G; Martinez J; McKean ML; De La Rosa J; Burke JF; Murphy S
    Am J Med; 1985 Nov; 79(5):552-9. PubMed ID: 3933340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
    Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
    J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human platelet electrorotation change induced by activation: inducer specificity and correlation to serotonin release.
    Egger M; Donath E; Spangenberg P; Bimmler M; Glaser R; Till U
    Biochim Biophys Acta; 1988 Dec; 972(3):265-76. PubMed ID: 3143424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of thromboxane A2.
    Ambler J; Birch J; Maguire ED; Wallis RB
    Adv Exp Med Biol; 1985; 192():293-308. PubMed ID: 2939695
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of phentolamine on platelet aggregation, thromboxane B2 production and release reaction.
    Anfossi G; Trovati M; Mularoni E; Lanzio M; Massucco P; Emanuelli G
    Arch Int Pharmacodyn Ther; 1988; 296():144-54. PubMed ID: 2853612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet function abnormalities in response to arachidonic acid in the acute phase of myocardial infarction.
    McDaniel HG; Maddox WT; Poon MC; Rogers WJ; Rackley CE
    Am J Cardiol; 1983 Nov; 52(8):965-8. PubMed ID: 6416046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cigarette smoking and platelet function.
    Marasini B; Biondi ML; Barbesti S; Zatta G; Agostoni A
    Thromb Res; 1986 Oct; 44(1):85-94. PubMed ID: 3787563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A functional study of platelets in menstrual fluid.
    Rees MC; Demers LM; Anderson AB; Turnbull AC
    Br J Obstet Gynaecol; 1984 Jul; 91(7):667-72. PubMed ID: 6430339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between prolonged bleeding time and depletion of platelet dense granule ADP in patients with myelodysplastic and myeloproliferative disorders.
    Malpass TW; Savage B; Hanson SR; Slichter SJ; Harker LA
    J Lab Clin Med; 1984 Jun; 103(6):894-904. PubMed ID: 6233383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The peripheral serotonergic system and platelet aggregation in cyclosporin A-induced hypertensive rats.
    Reis F; Tavares P; Fontes Ribeiro CA; Antunes F; Teixeira F
    Thromb Res; 1999 Dec; 96(5):365-72. PubMed ID: 10605951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of heparin on platelet aggregation and release and thromboxane A2 production.
    Mohammad SF; Anderson WH; Smith JB; Chuang HY; Mason RG
    Am J Pathol; 1981 Aug; 104(2):132-41. PubMed ID: 7258300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovine platelet function and its inhibition by T-2 toxin.
    Gentry PA; Socha AS; Ross ML
    Vet Res Commun; 1987; 11(5):457-66. PubMed ID: 3127991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood platelets in cardiopulmonary bypass operations. Recovery occurs after initial stimulation, rather than continual activation.
    Zilla P; Fasol R; Groscurth P; Klepetko W; Reichenspurner H; Wolner E
    J Thorac Cardiovasc Surg; 1989 Mar; 97(3):379-88. PubMed ID: 2918735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet function in experimentally induced pancreatitis in the dog.
    Jacobs RM; Murtaugh RJ; Fertel RH
    Thromb Haemost; 1986 Apr; 55(2):197-200. PubMed ID: 3087002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoassay of human platelet factor 4(PF4, antiheparin factor) by radial immunodiffusion.
    Niewiarowski S; Lowery CT; Hawiger J; Millman M; Timmons S
    J Lab Clin Med; 1976 Apr; 87(4):720-33. PubMed ID: 818325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of atrial natriuretic factor on human platelet function.
    De Caterina R; Volpe M; Atlas SA; Weksler BB
    Life Sci; 1985 Oct; 37(15):1395-402. PubMed ID: 2931566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.